no image available Dickens & Co. "chemotherapy's Double Whammy: Bevacizumab Falls Short in Mitigating Anemia Risk" "A meta-analysis sheds light on the limitations of bevacizumab in reducing anemia risk associated with chemotherapy" Price: 27.00€